| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |